Retinoids and Acute Pancreatitis in ALL Patients

The Role of Retinoids

Scientists have discovered that retinoids, compounds derived from vitamin A, may aid individuals suffering from acute pancreatitis, particularly as an adverse effect of the cancer drug asparaginase. A diet abundant in vitamin A could potentially mitigate the severe complications associated with acute pancreatitis induced by this medication.

Understanding Asparaginase and Acute Lymphoblastic Leukemia

Asparaginase is the preferred treatment for acute lymphoblastic leukemia (ALL), the most prevalent cancer among children and young adults. Notably, drug-induced pancreatitis ranks among the primary causes of acute pancreatitis in this demographic.

Asparaginase-Associated Pancreatitis

Study Overview

A research team led by Dr. Sohail Husain, Chief of Pediatric Gastroenterology, Hepatology, and Nutrition at Stanford University, alongside Anil Goud Jegga, a computational biologist at Cincinnati Children’s Hospital Medical Center, investigated the interplay between vitamin A, asparaginase, and pancreatitis in ALL patients.

Prevalence of Asparaginase-Associated Pancreatitis

Asparaginase-associated pancreatitis affects approximately 2-10% of ALL patients treated with the drug, with about one-third experiencing acute pancreatitis. In patients with ALL, asparaginase treatment is crucial as cancer cells require asparagine for growth but cannot produce it independently.

Research Findings

Gene Expression and Health Records Analysis

The research employed a systems approach to assess factors influencing asparaginase-associated pancreatitis. Initial gene expression experiments indicated that the gene expression changes induced by asparaginase could be reversed by vitamin A and its analogs. Additionally, an examination of electronic health records from approved sources revealed a lower risk of acute pancreatitis among patients concurrently exposed to vitamin A.

Plasma Sample Screening

Plasma samples collected after a single dose of asparaginase indicated decreased circulating retinoids. The study also highlighted a correlation between reduced dietary vitamin A intake and an increased likelihood of developing acute pancreatitis.

Animal Model Insights

Experiments conducted on mice demonstrated that asparaginase treatment resulted in lowered retinol levels in the bloodstream. In human subjects, only 1.4% of patients receiving asparaginase developed pancreatitis while taking vitamin A, compared to 3.4% of those who did not receive vitamin A.

Dietary Intake Analysis

Further analysis of patients’ dietary intake revealed that low vitamin A levels during asparaginase treatment were associated with a higher risk of drug-induced pancreatitis.

Conclusion

This study underscores the potential of vitamin A supplementation in safeguarding against acute pancreatitis during asparaginase treatment for ALL. However, further research is necessary to determine the optimal dosage of vitamin A and whether dietary sources alone are adequate or if supplementation is essential.

Reference

Tsai CY, Saito T, Sarangdhar M, Abu-El-Haija M, et al. A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis. Sci Transl Med. 2023 Mar 15;15(687). https://doi.org/10.1126/scitranslmed.abn2110